Eucrates Biomedical Acquisition Corp. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported net income was USD 2.42 million compared to USD 3.82 million a year ago.
Eucrates Biomedical Acquisition Corp.
Equities
EUCR
VGG3141W1068
Investment Holding Companies
1st Jan change | Capi. | |
---|---|---|
+137.37% | 5.68B | |
+1.89% | 1.01B | |
+2.19% | 982M | |
+41.91% | 872M | |
+25.27% | 819M | |
+1.68% | 663M | |
+0.54% | 610M | |
-.--% | 600M | |
+21.31% | 552M |